KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS

The Lancet

Volumn 319, Issue 8276, 1982, Pages 826-829

  Hann, I M ^a,b   Corringham, R ^a,b   Keaney, M ^a,b   Noone, P ^a,b   Fox, J ^a,b   Szawatkowski, M ^a,b   Prentice, H G ^a,b   Blacklock, H A ^a,b   Shannon, M ^a,b   Gascoigne, E ^a,b   Boesen, E ^a,b   Hoffbrand, A V ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b Janssen Pharmaceutical Ltd ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; COLISTIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCYTOSINE; KETOCONAZOLE; MELPHALAN; MICONAZOLE; NEOMYCIN; NYSTATIN;

ACUTE LEUKEMIA; ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW APLASIA; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG COMPARISON; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MYCOSIS; NAUSEA; ORAL DRUG ADMINISTRATION; PREVENTION; PREVENTIVE MEDICINE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; THERAPY; VOMITING;

AMPHOTERICIN B; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; IMIDAZOLES; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; LEUKEMIA; MYCOSES; NEUTROPENIA; NYSTATIN; PIPERAZINES; RANDOM ALLOCATION;

EID: 0020064358     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(82)91874-8     Document Type: Article

References (26)

1. Infectious complications in the child with cancer
2. Treatment of opportunistic mycoses in the immunocompromised patient
3. Mechanism of action of antifungal drugs with special reference to the imidazole derivatives
4. Pharmacokinetics of ketoconazole in normal subjects
5. Ketoconazole, an antifungal drug for oral use
6. Treatment of chronic mucocutaneous candidiasis with ketoconazole: preliminary results of a controlled, double blind clinical trial
7. The use of oral ketoconazole in chronic resistant fungal infections of the skin
8. An evaluation of two years of clinical exprience with ketoconazole
9. Treatment of dermatomycoses with ketoconazole
10. Ketoconazole: a new drug for the treatment of paracoccidiomycosis
11. Toxic hepatitis during ketoconazole treatment
12. Haematologic malignancies and other marrow failure states. Progress in the management of complicating infections
13. Oral non-absorbable antibiotics prevent infection in acute non-lymphoblastic leukaemia
14. Antibiotic prophylaxis for patients in protective isolation
15. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia
16. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with highdose melphalan
17. Successful chemoprophylaxis for Pneumocystis carinii pneumonia
18. Rapid identification of Candida albicans septicaemia in man by gas-liquid chromatography
19. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples
20. General laboratory system for summarising clinical data